Impact of Acquired FXIII Deficiency on Morbidity and Mortality

Impact of Acquired FXIII Deficiency on Morbidity and Mortality Among Hospitalized Patients

Observational prospective study aiming to assess acquired FXIII deficiency implications in morbidity and mortality

All patients admitted to a large tertiary hospital with FXIII levels below 70% during their hospital stay are assessed. Data regarding patient background, blood transfusion, morbidity and mortality is registered.

Inclusion Criteria:

• FXIII levels < 70%

Exclusion Criteria:

• None